Transglutaminase IgG (tTG-IgG) is an antibody measured to aid in the diagnosis of celiac disease, particularly when IgA deficiency is present.
Transglutaminase-IgG is often considered in the context of tiredness, reduced capacity, brain fog, or chronic exhaustion. This short overview clarifies what the marker can contribute, where its limits are, and when symptom or illness context becomes more important.
Transglutaminase-IgG is commonly relevant when fatigue raises questions about iron status, storage depletion, or anemia-related complaints. It can provide an important clue, but it rarely explains the full symptom picture by itself.
Transglutaminase-IgG does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
Transglutaminase IgG (tTG-IgG) is an antibody directed against tissue transglutaminase, an enzyme involved in gluten metabolism. In celiac disease, the immune system mistakenly attacks this enzyme in the lining of the small intestine after gluten exposure. Testing for tTG-IgG is especially useful in individuals who have IgA deficiency, because the more commonly measured tTG-IgA may be falsely low or absent in these patients.
The test helps identify autoimmune reactivity to gluten and supports the diagnostic workup for celiac disease, often in conjunction with other antibody tests and intestinal biopsy.
A tTG-IgG level within or below the reference range (commonly 0–10 U/mL, lab-dependent; no standard SI equivalent) generally indicates no significant autoimmune reaction to tissue transglutaminase. In people consuming gluten, a normal result suggests celiac disease is less likely, though it does not fully exclude the diagnosis in all cases.
An elevated tTG-IgG level (above 10 U/mL, lab-dependent) may suggest an abnormal immune response to gluten, often seen in celiac disease. High values are particularly meaningful in individuals with selective IgA deficiency, where tTG-IgA testing is unreliable. Further evaluation, including endoscopy with small bowel biopsy, is typically required to confirm a diagnosis.
This result is not specific for ME/CFS or Long COVID. Read it together with the clinical question, symptoms, related findings and the laboratory reference range rather than in isolation.
Practical details are separated from the general FAQ so they are easier to find.
tTG-IgG is particularly helpful in people who are IgA deficient, because the standard tTG-IgA test can be falsely negative. About 2–3% of people with celiac disease have IgA deficiency, so measuring tTG-IgG helps to avoid missing the diagnosis in these individuals.
Transglutaminase-IgG is commonly relevant when fatigue raises questions about iron status, storage depletion, or anemia-related complaints. It can provide an important clue, but it rarely explains the full symptom picture by itself.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
You now know which questions can matter when reading this result. With Elara you can keep the value and its surrounding context together over time.
Save the lab value with its date so individual measurements do not get lost.
See previous measurements together instead of relying on a single snapshot.
View Transglutaminase IgG Antibody (tTG-IgG) alongside symptom, energy, sleep and PEM entries without assuming one caused the other.
Export your history as a PDF — structured for the next check-up.
Normal levels are typically less than 10 U/mL, but this cutoff varies by laboratory and assay method. Always interpret results with the provided reference range from your lab.
A high level indicates your immune system may be producing antibodies against tissue transglutaminase, often triggered by gluten. This is commonly seen in celiac disease, especially if you have an IgA deficiency. Your doctor may recommend additional tests, such as an intestinal biopsy, for confirmation.
Yes, sometimes tTG-IgG can be mildly elevated in other autoimmune conditions, liver diseases, or infections. Therefore, a positive result must be interpreted alongside other tests and clinical findings.
Transglutaminase-IgG does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
For many fatigue-related, inflammatory, hormonal, or recovery-linked markers, interpretation becomes stronger when symptoms, exertion response, and daily function are considered together.
Transglutaminase-IgG is rarely meaningful in isolation when fatigue, brain fog, or unstable capacity are central. The fatigue hub provides the broader lab-and-symptom context.
If symptoms worsen after activity with a delay, PEM often explains more than an isolated lab value alone.
Questionnaires help connect biomarkers to symptom patterns, functional limits, and patient-reported change over time.
Markers from the same system can add useful context when a single lab value is hard to interpret on its own.
No individual medical review is documented.
This English content was created with AI assistance and automatically validated. This is not an individual medical review.
These references support the information presented on this page.
https://www.gesundheit.gv.at/labor/laborwerte/autoimmun/laborwerte-ttga-igg-ttagq1.html
gesundheit.gv.at
https://www.uniklinik-ulm.de/fileadmin/default/09_Sonstige/Klinische-Chemie/Seiteninhalte/Seiteninhalte_T/IgG-_und_IgA-Autoantikoerper_gegen_Gewebstransglutaminase__FB-PAE_6_TRANS_OE.pdf
uniklinik-ulm.de
https://www.gesundheit.gv.at/labor/laborwerte/autoimmun/gliadin-igg.html
gesundheit.gv.at
https://edoc.ub.uni-muenchen.de/4297/1/Oberhammer_Verena.pdf
edoc.ub.uni-muenchen.de
https://leistungsverzeichnis.labor-gaertner.de/entry/2218
leistungsverzeichnis.labor-gaertner.de
https://healthmatters.io/understand-blood-test-results/t-transglutaminase-ttg-igg
healthmatters.io
https://flexikon.doccheck.com/de/Transglutaminase-Antik%C3%B6rper
flexikon.doccheck.com
https://tobias-lib.ub.uni-tuebingen.de/xmlui/bitstream/handle/10900/44689/pdf/Doktorarbeit_Zoeliakie_16.pdf?sequence=1&isAllowed=y
tobias-lib.ub.uni-tuebingen.de
https://www.niddk.nih.gov/health-information/professionals/clinical-tools-patient-management/digestive-diseases/celiac-disease-health-care-professionals
niddk.nih.gov
This information does not replace medical advice. Lab values should be assessed in the context of your medical history, the reason for testing and other findings. Elara provides health information for orientation — not diagnoses or treatment decisions.
Bring your lab values, symptoms and energy into one shared context — so you walk into your next appointment more informed and structured.
